During the past decade, CEPREF conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEPREF" #1 collaborator was "Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire" with 2 trials as a collaborator, "University of Bordeaux" with 2 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "Institut de Recherche pour le Developpement" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "CEPREF" are "HIV Infections" (2 trials) and "HPV - Anogenital Human Papilloma Virus Infection" (1 trials). Many other conditions were trialed in "CEPREF" in a lesser frequency.

Most popular intervention types in "CEPREF" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABC-3TC-EFV once a day" (1 trials), "AZT-3TC-LPV/r twice a day" (1 trials) and "HPV test with partial genotyping and VIA triage" (1 trials). Other intervention names were less common.

The vast majority of trials in "CEPREF" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CEPREF". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CEPREF, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CEPREF, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".